Loading company details...
Beta
Latest Form 4 (Sep 18, 2026): Ryan Lynch (Treasurer, Senior Vice President of Finance and Chief Accounting Officer): Sale of 240 shares, $4.3K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 18, 2026 | Ryan Lynch, Treasurer, Senior Vice President of Finance and Chief Accounting Officer | Sale | 240 | $4.3K |
| Sep 18, 2026 | Jan Pinkas, Chief Scientific Officer | Sale | 658 | $11.8K |
| Sep 18, 2026 | Ellie Eunkyung Im, Chief Medical Officer | Sale | 623 | $11.2K |
| Sep 18, 2026 | Richard William Scalzo, Chief Financial Officer | Sale | 568 | $10.2K |
| Sep 18, 2026 | Barbara Harlin Bispham, General Counsel and Corporate Secretary | Sale | 620 | $11.1K |
| Sep 18, 2026 | Joshua T. Brumm, Chief Executive Officer | Sale | 1,610 | $28.8K |
| Sep 18, 2026 | Jonathan McNeill, President and COO | Sale | 731 | $13.1K |
| Jul 20, 2026 | Fairmount Funds Management LLC | Purchase | 853,450 | $12.38M |
| Jun 23, 2026 | Ryan Lynch, Treasurer, Senior Vice President of Finance and Chief Accounting Officer | Sale | 465 | $8.4K |
| Jun 23, 2026 | Jan Pinkas, Chief Scientific Officer | Sale | 1,288 | $23.2K |